Cervical Spondylotic Myelopathy Surgical Trial
2 other identifiers
interventional
269
2 countries
16
Brief Summary
The purpose of the study is to determine the optimal surgical approach (ventral vs dorsal) for patients with multi-level cervical spondylotic myelopathy (CSM). There are no established guidelines for the management of patients with CSM, which represents the most common cause of spinal cord injury and dysfunction in the US and in the world. This study aims to test the hypothesis that ventral surgery is associated with superior Short Form-36 physical component Score (SF-36 PCS) outcome at one year follow-up compared to dorsal approaches and that both ventral and dorsal surgery improve symptoms of spinal cord dysfunction measured using the modified Japanese Orthopedic Association Score (mJOA). A secondary hypothesis is that health resource utilization for ventral surgery, dorsal fusion, and laminoplasty surgery are different. A third hypothesis is that cervical sagittal balance post-operatively is a significant predictor of SF-36 PCS outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2014
Longer than P75 for not_applicable
16 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2014
CompletedFirst Posted
Study publicly available on registry
March 3, 2014
CompletedStudy Start
First participant enrolled
April 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2018
CompletedResults Posted
Study results publicly available
July 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
ExpectedFebruary 20, 2026
February 1, 2026
4 years
February 26, 2014
May 7, 2021
February 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measurement of Change in Short Form 36 (SF 36) Physical Component Score (PCS) From Baseline to 1 Year and 2 Year
Standardized measure of patient's functional health and well being as reported by the patient. The SF-36 physical component summary (PCS) scores range from 0 to 100, with higher scores representing better quality of life.
1 year and 2 year
Secondary Outcomes (9)
Short Form-36 (SF-36) Physical Component Summary (PCS) Score
Pre-operative, 1 year and 2 year
Oswestry Neck Disability Index (NDI)
Pre-operative, 1 year and 2 year
EuroQol-5D
Pre-operative, 1 year and 2 year
Modified Japanese Orthopedic Association Score mJOA
Pre-operative and 1 year
Sagittal Balance Measurements
1 year
- +4 more secondary outcomes
Other Outcomes (1)
Short Form-36 (SF-36) Physical Component Summary (PCS) Score by Actual Treatment Groups - Ventral Fusion, Dorsal Fusion, and Dorsal Laminoplasty
Pre-operative, 1 year and 2 year
Study Arms (2)
Ventral
ACTIVE COMPARATORVentral Decompression with Fusion
Dorsal
ACTIVE COMPARATORDorsal Decompression with Fusion or Dorsal Laminoplasty
Interventions
Ventral decompression and fusion will be performed using a multi-level discectomy (including partial or single level corpectomy) with fusion and plating. Allograft will be used at each disc space and all compressive osteophytes will be removed using the operating microscope. Fixation will be performed with rigid, semi-constrained, or dynamic titanium plates to optimize fusion and minimize complications.
Dorsal decompression and fusion will be performed using midline cervical laminectomy with the application of lateral mass screws and rods for rigid fixation. All surgeons will use local bone and allograft as needed to perform a lateral mass fusion, which typically will include one level rostral to the levels decompressed.
Laminoplasty will be performed using an open-door approach with the application of plates and screws at each treated level. Ceramic or allograft laminar spacers (surgeon's choice) can be used with plates and screws to expand the canal diameter.
Eligibility Criteria
You may qualify if:
- CSM (≥2 levels of spinal cord compression from C3 to C7)
- Present with ≥2 of the following symptoms/signs: clumsy hands, gait disturbance, hyperreflexia, up going toes, bladder dysfunction.
You may not qualify if:
- C2-C7 kyphosis\>5º (measured in standing neutral cervical spine radiograph),
- Segmental kyphotic deformity (defined by ≥3 osteophytes extending dorsal to a C2-C7 dorsal-caudal line measured on cervical spine CT),
- Structurally significant ossification of posterior longitudinal ligament (OPLL - measured on cervical spine CT),
- Previous cervical spine surgery
- Significant active health-related co-morbidity (Anesthesia Class IV or higher).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lahey Cliniclead
- Patient-Centered Outcomes Research Institutecollaborator
Study Sites (16)
University of California- San Francisco
San Francisco, California, 94143, United States
Emory
Atlanta, Georgia, 30329, United States
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
Lahey Hospital and Medical Center
Burlington, Massachusetts, 01805, United States
Washington University School of Medicine- St. Louis
St Louis, Missouri, 63110, United States
Rutgers-New Jersey Medical School
Newark, New Jersey, 07103, United States
Hospital for Special Surgery
New York, New York, 10021, United States
Columbia
New York, New York, 10032, United States
Cleveland Clinic Foundation
Cleveland, Ohio, 44106, United States
MetroHealth
Cleveland, Ohio, 44109, United States
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
University of Utah Health Sciences
Salt Lake City, Utah, 84132, United States
University of Wisconsin
Madison, Wisconsin, 53792, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
University Health Network-University of Toronto
Toronto, Ontario, M5T2S8, Canada
Related Publications (6)
Ghogawala Z, Martin B, Benzel EC, Dziura J, Magge SN, Abbed KM, Bisson EF, Shahid J, Coumans JV, Choudhri TF, Steinmetz MP, Krishnaney AA, King JT Jr, Butler WE, Barker FG 2nd, Heary RF. Comparative effectiveness of ventral vs dorsal surgery for cervical spondylotic myelopathy. Neurosurgery. 2011 Mar;68(3):622-30; discussion 630-1. doi: 10.1227/NEU.0b013e31820777cf.
PMID: 21164373BACKGROUNDGhogawala Z, Coumans JV, Benzel EC, Stabile LM, Barker FG 2nd. Ventral versus dorsal decompression for cervical spondylotic myelopathy: surgeons' assessment of eligibility for randomization in a proposed randomized controlled trial: results of a survey of the Cervical Spine Research Society. Spine (Phila Pa 1976). 2007 Feb 15;32(4):429-36. doi: 10.1097/01.brs.0000255068.94058.8a.
PMID: 17304133BACKGROUNDGhogawala Z, Benzel EC, Heary RF, Riew KD, Albert TJ, Butler WE, Barker FG 2nd, Heller JG, McCormick PC, Whitmore RG, Freund KM, Schwartz JS. Cervical spondylotic myelopathy surgical trial: randomized, controlled trial design and rationale. Neurosurgery. 2014 Oct;75(4):334-46. doi: 10.1227/NEU.0000000000000479.
PMID: 24991714BACKGROUNDRoguski M, Benzel EC, Curran JN, Magge SN, Bisson EF, Krishnaney AA, Steinmetz MP, Butler WE, Heary RF, Ghogawala Z. Postoperative cervical sagittal imbalance negatively affects outcomes after surgery for cervical spondylotic myelopathy. Spine (Phila Pa 1976). 2014 Dec 1;39(25):2070-7. doi: 10.1097/BRS.0000000000000641.
PMID: 25419682BACKGROUNDGhogawala Z, Terrin N, Dunbar MR, Breeze JL, Freund KM, Kanter AS, Mummaneni PV, Bisson EF, Barker FG 2nd, Schwartz JS, Harrop JS, Magge SN, Heary RF, Fehlings MG, Albert TJ, Arnold PM, Riew KD, Steinmetz MP, Wang MC, Whitmore RG, Heller JG, Benzel EC. Effect of Ventral vs Dorsal Spinal Surgery on Patient-Reported Physical Functioning in Patients With Cervical Spondylotic Myelopathy: A Randomized Clinical Trial. JAMA. 2021 Mar 9;325(10):942-951. doi: 10.1001/jama.2021.1233.
PMID: 33687463BACKGROUNDMiranda SP, Whitmore RG, Kanter A, Mummaneni PV, Bisson EF, Barker FG 2nd, Harrop J, Magge SN, Heary RF, Fehlings MG, Albert TJ, Arnold PM, Riew KD, Steinmetz MP, Wang MC, Heller JG, Benzel EC, Ghogawala Z. Patients May Return to Work Sooner After Laminoplasty: Occupational Outcomes of the Cervical Spondylotic Myelopathy Surgical Trial. Neurosurgery. 2025 Jan 1;96(1):131-141. doi: 10.1227/neu.0000000000003048. Epub 2024 Jun 24.
PMID: 38912784DERIVED
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Zoher Ghogawala, MD
- Organization
- Lahey Hospital & Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Zoher Ghogawala, MD
Lahey Clinic, Inc.
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2014
First Posted
March 3, 2014
Study Start
April 1, 2014
Primary Completion
March 30, 2018
Study Completion (Estimated)
December 30, 2026
Last Updated
February 20, 2026
Results First Posted
July 20, 2021
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will be available after publication of the trial's primary results.
- Access Criteria
- Researchers whose proposed use of data has been approved with a signed data use agreement.
Deidentified data will be available after publication of the trial's primary outcome results. Requests can be emailed to zoher.ghogawala@lahey.org.